Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
Catherine S. Manno(Children's Hospital of Philadelphia), Glenn F. Pierce(Epigen Biosciences (United States)), Valder R. Arruda(Children's Hospital of Philadelphia), Bertil Glader(Stanford University), Margaret V. Ragni(Hemophilia Center of Western Pennsylvania), John E.J. Rasko(Royal Prince Alfred Hospital), Margareth C. Ozelo(Universidade Estadual de Campinas (UNICAMP)), Keith Hoots(The University of Texas Health Science Center at Houston), Philip M. Blatt(Christiana Hospital), Barbara A. Konkle(Penn Presbyterian Medical Center), Michael D. Dake(Stanford University), Robin Kaye(Children's Hospital of Philadelphia), Mahmood Razavi(Stanford University), Albert Zajko(Penn Presbyterian Medical Center), James L. Zehnder(Stanford University), Pradip K. Rustagi(Stanford University), Hiroyuki Nakai(Stanford University), Amy Chew(Children's Hospital of Philadelphia), Debra G. B. Leonard(Cornell University), J Fraser Wright(Epigen Biosciences (United States)), Ruth Lessard(Epigen Biosciences (United States)), Jürg M. Sommer(Epigen Biosciences (United States)), Michael Tigges(Epigen Biosciences (United States)), Denise E. Sabatino(Children's Hospital of Philadelphia), Alvin Luk(Epigen Biosciences (United States)), Haiyan Jiang(Epigen Biosciences (United States)), Federico Mingozzi(Children's Hospital of Philadelphia), Linda Couto(Epigen Biosciences (United States)), Hildegund C.J. Ertl(The Wistar Institute), Katherine A. High(Children's Hospital of Philadelphia), Mark A. Kay(Stanford University)
Cited by 2,129
Abstract
Related Papers
No related papers found
Powered by citation graph analysis